Skip to main content

You are currently viewing a beta version of this site; please send improvements to contact@openomb.org.

Public Health and Social Services Emergency Fund

Schedules

TAFS: 075-0140 /X - Public Health and Social Services Emergency Fund

Iterations:
Adjustment authority: Yes
Reporting categories: No
Line #SplitDescriptionAmountFootnotes
1000DEDiscretionary Estimated Unob Bal: Brought forward, Oct 1$84,622,148,188.00
1000MEMandatory Estimated Unob Bal: Brought forward, Oct 1$13,005,078.00
1920Total budgetary resources avail (disc. and mand.)$84,635,153,266.00
6001Category A -- 1st quarter$17,242.00
6013Strategic National Stockpile$186,883,798.00 See footnotes below
Footnotes for line 6013:

A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent.

6015Pandemic Influenza (Vaccines, Antivirals & Diagnostics)$1,372,597.00
6016Pandemic Influenza (Facilities, Vaccines, Antivirals, and Diagnostics)$460,041.00
6017Pandemic Influenza (Other HHS Activities)$4,573,608.00
6018Pandemic Influenza (Other CDC Activities)$651,478.00
6019Parklawn Lease Replacement$441,978.00
6021Haiti CDC$7,508,952.00
6024HHS Lease Replacements$1,183,003.00
6025Project BioShield$850,059,794.00 See footnotes below
Footnotes for line 6025:

A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent.

6026Pandemic Influenza$97,940,017.00 See footnotes below
Footnotes for line 6026:

A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent.

6027NDMS$69,924.00
6028Bioterrorism$724,333.00
6029CDC Capacity$74,317.00
6030Natural Disasters$4,888,792.00
6032CDC Preparedness$175,229.00
6036Pediatric Disaster Care$13,005,078.00
6037Coronavirus 2 Testing for the Uninsured$1,706,914.00 See footnotes below
Footnotes for line 6037:

A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.

A6: Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.

6038Coronavirus 3 Healthcare Provider Reimbursements$2,500,578,549.00 See footnotes below
Footnotes for line 6038:

A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available.

A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.

6039Coronavirus 4 Healthcare Provider Reimbursements$33,189,785,643.00 See footnotes below
Footnotes for line 6039:

A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available.

A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.

6040Coronavirus 4 Allocations to State, Local, Tribal and other entities$257,172,556.00 See footnotes below
Footnotes for line 6040:

A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.

6041Coronavirus 4 BARDA$967,079.00 See footnotes below
Footnotes for line 6041:

A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.

6042Coronavirus 4 Testing for Uninsured$2,900.00 See footnotes below
Footnotes for line 6042:

A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.

A6: Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.

6043Coronavirus 4 Rural Health Clinics Testing$3,214,991.00 See footnotes below
Footnotes for line 6043:

A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.

6044Coronavirus 4 HHS Response Activities$335,766,847.00 See footnotes below
Footnotes for line 6044:

A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.

A7: Funds are available immediately for obligation consistent with the July 21, 2021 PPPHCEA Testing Spend Plan, and any updates to that plan. Within the total for the Testing Spend Plan, HHS may update this plan by increasing or decreasing any line by the lesser of $500,000 or 5%. HHS must notify OMB within five business days of any such change by providing an updated Testing Spend Plan and supporting rationale.

6046Coronavirus 5 Healthcare Provider Reimbursements$3,000,000,000.00 See footnotes below
Footnotes for line 6046:

A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available.

A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.

6047Coronavirus 6 Healthcare Provider Reimbursements$8,500,000,000.00 See footnotes below
Footnotes for line 6047:

A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB.

6048Coronavirus 6 Testing, Contact Tracing, and Mitigation Activities$25,098,883,573.00 See footnotes below
Footnotes for line 6048:

A13: Funds are available immediately for obligation consistent with the September 3, 2021, Section 2401 Testing Spend Plan. Funds are available for additional activities five business days after HHS provides OMB notification of spending plans.

6049Coronavirus 6 Public Health Workforce$4,908,255,785.00 See footnotes below
Footnotes for line 6049:

A9: Of this total, $740,755,785 is available immediately for obligation consistent with the previously approved Public Health Workforce FY 2021 spend plan. Funds are available for additional projects five business days after an HHS approved spend plan has been submitted to OMB.

6050Coronavirus 6 Strategic National Stockpile$850,000,000.00 See footnotes below
Footnotes for line 6050:

A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB.

6051Coronavirus 6 Antivirals$3,118,578,248.00
6052Coronavirus 6 Vaccines, Therapeutics, and Medical Supplies$1,602,710,000.00 See footnotes below
Footnotes for line 6052:

A14: Funds are available immediately for obligation consistent with the September 30, 2021 FY 22 Operation Spending Plan. HHS will promptly notify OMB of changes by the lesser of $10,000,000 or 10 percent in the cost of those contracts, IAAs, and IDDAs. Funds are available for additional projects five business days after HHS provides OMB notification of spending plans.

6053Coronavirus 6 Medical Reserve Corps$97,500,000.00 See footnotes below
Footnotes for line 6053:

A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB.

6190Total budgetary resources available$84,635,153,266.00 See footnotes below
Footnotes for line 6190:

A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet.

A2: Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments.

A3: The multiple category B lines for Pandemic Influenza are used because some appropriations had more broad legal authorities than others. Obligations may be funded from multiple category B lines provided that the obligation is consistent with the purpose of the appropriation.

A4: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available, plus the amount governed by footnote A10. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources.

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet.
A10
Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available.
A11
For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent.
A12
HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139.
A13
Funds are available immediately for obligation consistent with the September 3, 2021, Section 2401 Testing Spend Plan. Funds are available for additional activities five business days after HHS provides OMB notification of spending plans.
A14
Funds are available immediately for obligation consistent with the September 30, 2021 FY 22 Operation Spending Plan. HHS will promptly notify OMB of changes by the lesser of $10,000,000 or 10 percent in the cost of those contracts, IAAs, and IDDAs. Funds are available for additional projects five business days after HHS provides OMB notification of spending plans.
A2
Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments.
A3
The multiple category B lines for Pandemic Influenza are used because some appropriations had more broad legal authorities than others. Obligations may be funded from multiple category B lines provided that the obligation is consistent with the purpose of the appropriation.
A4
The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available, plus the amount governed by footnote A10. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources.
A5
Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.
A6
Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act.
A7
Funds are available immediately for obligation consistent with the July 21, 2021 PPPHCEA Testing Spend Plan, and any updates to that plan. Within the total for the Testing Spend Plan, HHS may update this plan by increasing or decreasing any line by the lesser of $500,000 or 5%. HHS must notify OMB within five business days of any such change by providing an updated Testing Spend Plan and supporting rationale.
A8
Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB.
A9
Of this total, $740,755,785 is available immediately for obligation consistent with the previously approved Public Health Workforce FY 2021 spend plan. Funds are available for additional projects five business days after an HHS approved spend plan has been submitted to OMB.

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.